Early Findings of AI Study at Frimley Health NHS Foundation Trust Show 99.7% Accuracy in Triaging Chest X-rays as Normal

Qure.aiFrimley Health NHS Foundation Trust and Qure.ai have announced the early results of a pilot study using an innovative radiology AI solution to read and differentiate between normal and abnormal chest X-rays (CXRs).

qXR, a CE class IIb MDR cleared solution developed by Qure, was deployed with the hypothesis to categorise normal x-rays - approximately 40% of the caseload from GP and outpatient requests - and augment overall reporting efficiency. The aim of the study was to highlight AI’s potential role in optimising radiology department workflows, to boost efficiency and enhance patient outcomes.

Early results show 99.7% accuracy in triaging CXRs as normal, with the potential to reduce consultant radiologist’s workload by up to 58% by transferring cases to radiographer reporting workload. This could save consultant radiologists up to 2 hours per day, freeing up time to concentrate on specialist and complex imaging reports.

Additionally, the qXR AI identified all cancer cases, including inconspicuous cancer risk nodules that may traditionally remain unnoticed. This heralds the potential of using AI for early detection and treatment of lung cancer.

Dr Amrita Kumar, Consultant Radiologist and AI Clinical Lead at Frimley Health NHS Foundation Trust states, "AI offers a transformative advantage to Frimley Health NHS Foundation Trust, enabling efficient triage of normal chest X-rays and empowering radiologists to focus on complex cases. By optimising efficiency, Qure's qXR Chest X-ray solution contributes to better patient outcomes and addresses the critical need for innovative AI solutions in the radiology department."

Darren Stephens, Senior Vice President & Commercial Head UK and Europe of Qure.ai comments, "The ongoing radiologist shortage, now estimated by Royal College of Radiologists to be 40% by 2027, underscores the importance of healthcare AI to help augment the precious human resource that currently exists, and ensure the delivery of the highest standard of patient care into the future. The qXR study at Frimley Health NHS Foundation Trust is testimony to the clinical leadership at the Trust in embracing AI as an opportunity for positive change."

For further information, please visit:
https://qure.ai

About Qure.ai

Qure.ai is a health tech company that uses deep learning and Artificial Intelligence (AI) tools to make healthcare more accessible and affordable to patients around the world in medical imaging & care coordination. Our technology fulfils a pertinent, unmet need in the radiology industry. With the aid of tools like those developed by Qure.ai, which work via a sophisticated set of algorithms that can instantly evaluate scans to prioritize actionable patient cases quickly, radiologists can focus their time and advanced skill sets on the most pressing diagnoses.

Most Popular Now

Most Advanced Artificial Touch for Brain…

For the first time ever, a complex sense of touch for individuals living with spinal cord injuries is a step closer to reality. A new study published in Science, paves...

Predicting the Progression of Autoimmune…

Autoimmune diseases, where the immune system mistakenly attacks the body's own healthy cells and tissues, often have a preclinical stage before diagnosis that’s characterized by mild symptoms or certain antibodies...

Major EU Project to Investigate Societal…

A new €3 million EU research project led by University College Dublin (UCD) Centre for Digital Policy will explore the benefits and risks of Artificial Intelligence (AI) from a societal...

Using AI to Uncover Hospital Patients�…

Across the United States, no hospital is the same. Equipment, staffing, technical capabilities, and patient populations can all differ. So, while the profiles developed for people with common conditions may...

New AI Tool Uses Routine Blood Tests to …

Doctors around the world may soon have access to a new tool that could better predict whether individual cancer patients will benefit from immune checkpoint inhibitors - a type of...

New Method Tracks the 'Learning Cur…

Introducing Annotatability - a powerful new framework to address a major challenge in biological research by examining how artificial neural networks learn to label genomic data. Genomic datasets often contain...

Picking the Right Doctor? AI could Help

Years ago, as she sat in waiting rooms, Maytal Saar-Tsechansky began to wonder how people chose a good doctor when they had no way of knowing a doctor's track record...

From Text to Structured Information Secu…

Artificial intelligence (AI) and above all large language models (LLMs), which also form the basis for ChatGPT, are increasingly in demand in hospitals. However, patient data must always be protected...

AI Innovation Unlocks Non-Surgical Way t…

Researchers have developed an artificial intelligence (AI) model to detect the spread of metastatic brain cancer using MRI scans, offering insights into patients’ cancer without aggressive surgery. The proof-of-concept study, co-led...

Deep Learning Model Helps Detect Lung Tu…

A new deep learning model shows promise in detecting and segmenting lung tumors, according to a study published in Radiology, a journal of the Radiological Society of North America (RSNA)...

One of the Largest Global Surveys of Soc…

As leaders gather for the World Economic Forum Annual Meeting 2025 in Davos, Leaps by Bayer, the impact investing arm of Bayer, and Boston Consulting Group (BCG) announced the launch...

New Study Reveals AI's Transformati…

Intensive care units (ICUs) face mounting pressure to effectively manage resources while delivering optimal patient care. Groundbreaking research published in the INFORMS journal Information Systems Research highlights how a novel...